Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine
Melanie Kripp, Ralf-Dieter HofheinzOnkologisches Zentrum, III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, GermanyAbstract: Liposomal encapsulated cytarabine (DepoCyte®, Mundipharma GmbH, Limburg/Lahn, Germany) is a slow-relea...
Guardado en:
Autores principales: | Melanie Kripp, Ralf-Dieter Hofheinz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7235414629a54c10b36467883a4fcbc5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases
por: Cosco D, et al.
Publicado: (2012) -
Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]
por: Alekseeva AS, et al.
Publicado: (2017) -
CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties
por: Mayer LD, et al.
Publicado: (2019) -
Tat-functionalized liposomes for the treatment of meningitis: an in vitro study
por: Bartomeu Garcia C, et al.
Publicado: (2017) -
Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes
por: Preety Panwar, et al.
Publicado: (2010)